National Breast Cancer Foundation launched its new five-year research strategy on 9 November.
NBCF has undertaken a process of broad consultation informed by evidence, scientific and clinical expertise, lived-experience perspectives, and strategic insight to develop this new research strategy. Cancer Voices has contributed to the consultation process.
Under the new Pink Horizon Research Strategy NBCF will provide up to $125 million of funding over the next five years to support research focused on one or more of our four key objectives across three connected grants schemes:
The four key objectives:
- Prevent – Prevent breast cancer through precision prevention.
- Detect – Detect breast cancer as early as possible and before it progresses.
- Stop – Stop the progression and recurrence of breast cancer.
- Treat – Treat hard to treat and metastatic breast cancer.
The three grant schemes:
- Collaborative Research Accelerator Grants – foster and ecosystem of multidisciplinary researchers from different institutions and at different career stages that will address the most critical questions in breast cancer. Each accelerator will be funded up to $25 million over five years.
- Research Project Grants – provide support for investigator-initiated research projects with a clear line of sight to achieve Zero Deaths from breast cancer.
- Pink Sky Grants – Support high risk, high reward research projects with significant paradigm shifting potential to revolutionise approaches to combating breast cancer.
For more information, please visit https://nbcf.org.au/research-strategy/